In this revised submission, the University of North Carolina at Chapel Hill (UNC) Divisions of Adult and Pediatric Hematology/Oncology, the Department of Radiation Oncology, the UNC Lineberger Comprehensive Cancer Center (UNC-LCCC) and the Division of Gastroenterology and Hepatology propose to create the UNC Oncology Clinical/Translational Research Training Program (OCT-RTP). All four of the components will contribute mentors and research resources to the proposed training program, and all components except UNC-LCCC will contribute scholars. OCT-RTP will admit two scholars per year. Thus, in Year One, the Program will sponsor two scholars. In Years Two - Five, the Program will sponsor four scholars (two new, two continuing). The PI, Dr. Richard Goldberg, is Professor and Chief of Hematology/Oncology and UNC-LCCC Associate Director for Clinical Research and has extensive experience in the direction, planning, and execution of oncology clinical trials. The program's objectives are to establish a highly motivated and rigorously trained cadre of physician clinical researchers who are competitive in seeking research support and who will become successful, independent patient-oriented cancer investigators. Training resources that will be available for the OCT-RTP include: the Lineberger Comprehensive Cancer Center, the North Carolina Cancer Hospital, the UNC School of Medicine K30 Clinical Research Curriculum and the UNC Program on Ethnicity Culture and Health Outcomes. X The goals of the OCT-RTP are to increase the quality and quantity of patient-oriented research, including all phases of clinical research and particularly that involving a translational component. The foundation of the proposed training program will be the participation of highly qualified basic science and clinical mentors assigned to each scholar with mentoring activities coordinated by a mentor integration panel. An internal advisory committee that includes senior faculty from each of the four components will select and monitor the progress of scholars, while an external advisory committee will review the program annually. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12CA120780-02
Application #
7498025
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lei, Ming
Project Start
2007-09-17
Project End
2012-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
2
Fiscal Year
2008
Total Cost
$443,266
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Cuthbertson, Carmen C; Kucharska-Newton, Anna; Faurot, Keturah R et al. (2018) Controlling for Frailty in Pharmacoepidemiologic Studies of Older Adults: Validation of an Existing Medicare Claims-based Algorithm. Epidemiology 29:556-561
Williams, Grant R; Deal, Allison M; Muss, Hyman B et al. (2018) Frailty and skeletal muscle in older adults with cancer. J Geriatr Oncol 9:68-73
Saito, Ryoichi; Smith, Christof C; Utsumi, Takanobu et al. (2018) Molecular Subtype-Specific Immunocompetent Models of High-Grade Urothelial Carcinoma Reveal Differential Neoantigen Expression and Response to Immunotherapy. Cancer Res 78:3954-3968
Agle, Kimberle; Vincent, Benjamin G; Piper, Clint et al. (2018) Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD. Blood 132:435-447
Williams, Grant R; Deal, Allison M; Sanoff, Hanna K et al. (2018) Frailty and health-related quality of life in older women with breast cancer. Support Care Cancer :
Bryant, Ashley Leak; Deal, Allison M; Battaglini, Claudio L et al. (2018) The Effects of Exercise on Patient-Reported Outcomes and Performance-Based Physical Function in Adults With Acute Leukemia Undergoing Induction Therapy: Exercise and Quality of Life in Acute Leukemia (EQUAL). Integr Cancer Ther 17:263-270
Molenaar, Remco J; Maciejewski, Jaroslaw P; Wilmink, Johanna W et al. (2018) Wild-type and mutated IDH1/2 enzymes and therapy responses. Oncogene 37:1949-1960
Williams, Grant R; Deal, Allison M; Shachar, Shlomit Strulov et al. (2018) The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer. Cancer Chemother Pharmacol 81:413-417
Lund, Jennifer L; Sanoff, Hanna K; Peacock Hinton, Sharon et al. (2018) Potential Medication-Related Problems in Older Breast, Colon, and Lung Cancer Patients in the United States. Cancer Epidemiol Biomarkers Prev 27:41-49
Bryant, Ashley Leak; Coffman, Erin M; Bullard, Elizabeth et al. (2018) Experiences of Inpatient Bone Marrow Transplantation Nurses and Providers Using Electronic Symptom Reporting. J Oncol Pract 14:e496-e504

Showing the most recent 10 out of 128 publications